NCT05630521Completed
Testing Feasibility of Medication Adherence Problem Solving for Hypertension
Testing Feasibility of the Medication Adherence Problem Solving for Hypertension (MASH) Intervention to Improve Antihypertensive Medication Adherence
Source: ClinicalTrials.gov · Last updated 2 Oct 2024
Brief summary (registry, in English)
Adherence to medications for high blood pressure is key to improving blood pressure control and reducing the impact of cardiovascular disease. This project will test the feasibility of a tailored telehealth intervention to help patients improve adherence to blood pressure medication.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 40 (actual)
- First submitted
- 4 Nov 2022
- Start date
- 20 Feb 2023
- Primary completion date
- 25 Aug 2024
- Lead sponsor
- Rush University Medical Center
- Diseases
- High blood pressure
- NCT number
- NCT05630521
What you commit to
- Study type: Interventional
- Participants enrolled: 40
- From 20 Feb 2023 to the primary completion date, 25 Aug 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Acutely ill (e.g., symptoms of myocardial infarction, respiratory distress, stroke)
- Patients who have end-stage renal disease (ESRD) and/or are on dialysis
- Terminal chronic illness with a life expectancy of 6 months or less
Other
- In state of hypertensive crisis (SBP \>180 and/or DBP \> 120 mmHg) at the time of study screening. Any participant in hypertensive crisis will be referred to their health care provider immediately for further instruction and follow-up, per current guidelines2
- BP measurement is contraindicated on both upper extremities
Who the study is looking for
- Aged ≥ 18 years at time of study entry
- Able to read, write, and converse in English
- Have an active prescription for at least one HTN medication, reporting no antihypertensive prescription changes for 30 days prior to study entry
- Have prescription drug coverage or participate in a prescription assistance program that covers medication costs.
- Diagnosis of HTN, based on self-report or confirmed through medical records, where available. (Self-reported high BP has long been shown to be strongly correlated with presence of a HTN diagnosis.22-24 Self-report combined with presence of a prescribed HTN medication ensures that only participants with HTN will be included)
- Must self-administer their own medications
- Uncontrolled BP: systolic (SBP) ≥ 130 mmHg and/or diastolic (DBP) ≥ 80 mmHg at baseline
- Nonadherent to HTN medication (Hill-Bone Medication Subscale score \< 36) at screening
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Rush University Medical Center Coordinator of this site? Confirm its status | Chicago | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.